As of 2025-11-13, the EV/EBITDA ratio of Immunovia AB (publ) (IMMNOV.ST) is -2.33. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMMNOV.ST's latest enterprise value is 211.35 mil SEK. IMMNOV.ST's TTM EBITDA according to its financial statements is -90.76 mil SEK. Dividing these 2 quantities gives us the above IMMNOV.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 10.3x | 8.0x |
| Forward P/E multiples | 9.3x - 12.5x | 10.6x |
| Fair Price | (1.32) - (1.46) | (1.32) |
| Upside | -500.5% - -542.7% | -501.6% |
| Date | EV/EBITDA |
| 2025-11-11 | -2.33 |
| 2025-11-10 | -2.37 |
| 2025-11-07 | -2.31 |
| 2025-11-06 | -2.22 |
| 2025-11-05 | -2.14 |
| 2025-11-04 | -2.20 |
| 2025-11-03 | -2.25 |
| 2025-10-31 | -2.25 |
| 2025-10-30 | -2.23 |
| 2025-10-29 | -2.37 |
| 2025-10-28 | -2.42 |
| 2025-10-27 | -2.28 |
| 2025-10-24 | -2.30 |
| 2025-10-23 | -2.30 |
| 2025-10-22 | -2.08 |
| 2025-10-21 | -2.12 |
| 2025-10-20 | -2.31 |
| 2025-10-17 | -2.36 |
| 2025-10-16 | -2.31 |
| 2025-10-15 | -2.33 |
| 2025-10-14 | -2.34 |
| 2025-10-13 | -2.40 |
| 2025-10-10 | -2.46 |
| 2025-10-09 | -2.41 |
| 2025-10-08 | -2.36 |
| 2025-10-07 | -2.36 |
| 2025-10-06 | -2.61 |
| 2025-10-03 | -2.79 |
| 2025-10-02 | -2.84 |
| 2025-10-01 | -2.87 |
| 2025-09-30 | -2.75 |
| 2025-09-29 | -2.76 |
| 2025-09-26 | -3.35 |
| 2025-09-25 | -3.32 |
| 2025-09-24 | -3.55 |
| 2025-09-23 | -3.55 |
| 2025-09-22 | -3.62 |
| 2025-09-19 | -3.82 |
| 2025-09-18 | -4.03 |
| 2025-09-17 | -4.19 |
| 2025-09-16 | -4.36 |
| 2025-09-15 | -4.65 |
| 2025-09-12 | -4.48 |
| 2025-09-11 | -4.52 |
| 2025-09-10 | -4.38 |
| 2025-09-09 | -4.52 |
| 2025-09-08 | -4.71 |
| 2025-09-05 | -4.55 |
| 2025-09-04 | -4.85 |
| 2025-09-03 | -5.17 |